NCT06474650View on ClinicalTrials.gov

Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

September 25, 2024

Study Completion Date

September 25, 2024

Conditions
Huntington DiseaseTardive Dyskinesia
Interventions
DRUG

LPM3770164 sustained release tablet

Single-dose of 30 mg of LPM3770164 sustained release tablet

Trial Locations (1)

Unknown

Shanghai Mental Health Center, Shanghai

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT06474650 - Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets | Biotech Hunter | Biotech Hunter